Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.53 |
| ▸ | LMNA | P02545 | 8/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.53 |
| ▸ | TP53 | P04637 | 4/20 | 0.53 |
| ▸ | CCR1 | P32246 | 3/20 | 0.53 |
| ▸ | CCR5 | P51681 | 3/20 | 0.53 |
| ▸ | CCR8 | P51685 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | GRM5 | P41594 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12257971 | 0.95 | SMN1; SMN2 (0.58) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL15249622 | 0.95 | SMN1; SMN2 (0.58) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL3596420 | 0.91 | CCR1 (0.55) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL21849866 | 0.91 | CCR1 (0.55) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL30943430 | 0.91 | CCR1 (0.55) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL30943427 | 0.91 | CCR1 (0.55) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL29505007 | 0.91 | CCR1 (0.55) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL3390446 | 0.90 | KDM4E (0.55) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL3320940 | 0.88 | CCR1 (0.51) | KDM4ELMNASMN1; SMN2TP53CCR1 | |
| SCHEMBL3392131 | 0.87 | KDM4E (0.51) | KDM4ELMNASMN1; SMN2TP53CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2246351-B1 | COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-8624228-B2 | Compound having pyridoindole ring structure bonded with substituted pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20100308322-A1 | COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | Hodogaya Chemical Co,. Ltd. (JP) | 2010-12-09 | — | — | US | disclosed |
| EP-2246351-A1 | COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2010-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100308322-A1 | COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE BONDED WITH SUBSTITUTED PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | KCNH3, KCNH2, PRDM9 | KDM4E 1240/4885LMNA 2167/4885SMN1; SMN2 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.